ADVANCED SOLID TUMORS
Clinical trials for ADVANCED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug trial halted early
Disease control TerminatedThis early-stage study tested an experimental drug called VVD-130850, which blocks a protein (STAT3) that helps cancers grow. The drug was given alone or with another immunotherapy to people with advanced solid tumors or blood cancers that had spread or could not be removed. The …
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Vividion Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:43 UTC
-
New cancer drug trial halted early – what we know
Disease control TerminatedThis study tested a new drug called ASP2074 in 23 adults with advanced solid tumors that had spread or couldn't be removed. The goal was to find a safe dose and check for side effects. The study was stopped early, so results are limited.
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 01, 2026 15:43 UTC
-
New cancer drug trial halted early – what we know
Disease control TerminatedThis early-stage trial tested a new drug called SIM0501, alone or with another drug (olaparib), in 13 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and how the drug moves through the body. The study was sto…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 15:42 UTC
-
New pill for Hard-to-Treat cancers enters early human testing
Disease control TerminatedThis early-stage study tested an experimental pill called ATX-559 in 17 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and see if the drug could shrink tumors. The study was terminated early, so results …
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:40 UTC
-
New immune drug combo tested for tough cancers
Disease control TerminatedThis early-stage study tested a new drug called FAZ053, alone or with another drug (PDR001), in 154 adults with advanced solid tumors (including triple-negative breast cancer and rare sarcomas). The main goal was to find safe doses and understand side effects. The study was stopp…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:39 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-stage study tested a new drug, PF-07265028, alone or with another drug (sasanlimab) in people with advanced solid tumors that had spread. The goal was to find a safe dose and see if the drug shrank tumors. The study was stopped early, and 21 people took part.
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 01, 2026 15:39 UTC
-
New cancer drug combo tested in early trial
Disease control TerminatedThis early-phase study tested a new drug called INCA00186, alone or with other immunotherapies, in 57 people with advanced solid tumors like head and neck or gastrointestinal cancers. The goal was to check safety, find the right dose, and see if the drug helps control the disease…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 01, 2026 15:39 UTC